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formation of molecular inclusion complexation of olanzapine with methyl-β-cyclodextrin. All the binary mixtures of olanzapine with methyl-β-cyclodextrin, except physical mixture, exhibited a faster and greater extent of drug dissolution than the drug alone. Products obtained by the supercritical carbon dioxide processing method exhibited the highest apparent drug dissolution. The characterisation by different analytical techniques suggests complete complexation or amorphisation of olanzapine and methyl-β-cyclodextrin complexes prepared by supercritical carbon dioxide processing method. Therefore, organic solvent-free supercritical carbon dioxide processing method proved to be novel and efficient for the preparation of solid inclusion complexes of olanzapine with methyl-β-cyclodextrin. The preliminary data also suggests that the complexes of olanzapine with methyl-β-cyclodextrin will lead to better therapeutic efficacy due to better solubility and dissolution properties.
ABBREVIATIONS
Me-β-CD: Methyl-β-cyclodextrin SC-CO2: Supercritical carbon dioxide SEM: Scanning electron microscopy DSC: Differential scanning calorimetry XRPD: X-ray powder diffraction
Introduction
Olanzapine is a second-generation atypical neuroleptic drug approved by the Food and Drug Administration as a first-line therapy for the treatment of schizophrenia and mania associated with bipolar disorder (Abdelbary and Tadros, 2013) . It suffers from poor aqueous solubility (12-44 µg mL -1 ) and a low dissolution rate leading to an erratic bioavailability (Kulkarni et al., 2010; Dixit et al., 2011; Raman et al., 2013) . Moreover, the drug undergoes extensive hepatic first-pass metabolism and is required in high doses (Sood et al., 2013) .
Several approaches have been reported to enhance the solubility and dissolution rate of olanzapine, e.g. solid-dispersions (Krishnamoorthy et al., 2011) , nano-emulsions (Raman et al., 2013) , solid-lipid nanoparticles (Sood et al., 2013) , freeze dried tablets (Dixit et al., 2011) and inclusion complexation with cyclodextrins (Kulkarni et al., 2010; de Freitas et al., 2012) .
Cyclodextrins, also known as cyclomaltoses, cycloamyloses and Schardinger dextrins, are macrocyclic oligomers of α-D-glucose with a hydrophilic exterior and a relatively non polar central cavity (Appel et al., 2012; Kfoury et al., 2014; Kfoury et al., 2015; Rudrangi et al., 2015) . Cyclodextrins can form inclusion complexes by taking up the entire or a part of lipophilic drug molecule in its hydrophobic interior cavity (Loftsson and Duchêne, 2007; Salústio et al., 2009) . Through formation of inclusion complexes, cyclodextrins are known to enhance the aqueous solubility and dissolution rate of poorly soluble drugs (Trapani et al., 2000; Pose-Vilarnovo et al., 2001; Latrofa et al., 2001; Jain and Adeyeye, 2001; Riekes et al., 2010) .
The study published by de Freitas et al. (2012) reported that olanzapine and methyl-β-cyclodextrin (Me-β-CD) complexes prepared in the 1:1 molar ratio using rotary evaporation method exhibit a higher dissolution profile than the active alone or in a state of physical mixture. Despite their success, the complex preparation by the stated method required an organic solvent which is not desirable. Removal of environmentally harmful organic solvents from the drug product to the levels approved by the Food and Drug Administration is very challenging and therefore conventional techniques used for the preparation of inclusion complexes (co-evaporation, spray drying and kneading) involve several drying steps for considerable time, which may also affect the drug stability (Al-Marzouqi et al., 2006) .
Hence, it is highly recommended to eliminate the use of organic solvents in the preparation of drugs or drug-cyclodextrin complexes.
The aim of the present study was to produce olanzapine-Me-β-CD complexes in the same stoichiometric ratios (1:1 molar) without using organic solvents or auxiliary agents.
Therefore, application of supercritical fluid processing was studied as an alternative to conventional methods in the current work.
A supercritical fluid is defined as a substance that exists above its critical pressure and temperature. Supercritical fluids feature densities like liquids and viscosities and diffusivities like gases and hence offer excellent mass transfer and solubilising properties (York, 1999; Kompella and Koushik, 2001; Sunkara and Kompella, 2002; Bandi et al., 2004) . Carbon dioxide becomes supercritical above 31.25 °C and 73.8 bar. Supercritical carbon dioxide (SC-CO2) is environmentally benign and is considered to be green. SC-CO2 is a noncombustible, non-toxic, recyclable and environment-friendly solvent (Palakodaty and York, 1999; Lang and Wai, 2001; Lee et al., 2008; Deshpande et al., 2011; Girotra et al., 2013; Rudrangi et al., 2015) and has provided an appealing alternative to toxic organic solvents or conventional complexation media. SC-CO2 has been successfully employed in the preparation of inclusion complexes between various drugs and cyclodextrins in dynamic or static modes (Table 1) .
The use of the SC-CO2 processing has already been investigated in the preparation of drugMe-β-CD inclusion complexes (Charoenchaitrakool et al., 2002; Banchero et al., 2013; Rudrangi et al., 2015) . A significant improvement in the dissolution rate of drug was observed in all cases. It was suggested by Banchero and co-workers (Banchero et al., 2013) that the liquefaction of Me-β-CD in SC-CO2 favours the complexation of drug and cyclodextrin without any addition of water or auxiliary agents as the drug molecules would better reach the cavity of the cyclodextrin in the molten or liquid state.
The effect of supercritical carbon dioxide processing on the preparation of olanzapine-Me-β-CD complexes has not yet been reported. Inclusion complexes were prepared by physical mixing, freeze drying, co-evaporation and SC-CO2 processing at various working (temperature and pressure) conditions. The prepared complexes were then characterized by solubility studies, differential scanning calorimetry, X-ray powder diffraction, scanning electron microscopy and dissolution studies.
Materials and methods

Materials
Olanzapine ( 
Preparation of binary mixtures of olanzapine with Me-β-CD
All binary mixtures of olanzapine with Me-β-CD were prepared in a 1:1 molar ratio. The processed samples were stored in a desiccator over solid calcium chloride until submitted for analysis.
Physical mixing
Physical mixture was obtained by tumble-mixing an accurately weighed equimolar mixture of olanzapine and Me-β-CD at 100 rpm for 15 minutes using a TURBULA® T2F mixer (Willy A. Bachofen AG -Maschinenfabrik, Muttenz, Switzerland).
Freeze drying
Olanzapine was added to the aqueous solution of Me-β-CD under constant stirring. The mixture was agitated in an orbital shaker at room temperature until equilibrium was attained (48 h). The resultant suspension was frozen at −60 °C and then lyophilized in a freeze-dryer (ScanVac CoolSafe, UK) for 48 h. The obtained product was sieved through 0.150 mm sieve.
Co-evaporation
An ethanolic solution of olanzapine was added to an aqueous solution of Me-β-CD and the mixture was agitated in an orbital shaker for 24 h. The solvents were then evaporated under reduced pressure to yield a pale yellowish, dry powder.
Supercritical carbon dioxide process
The complexes were prepared using an extraction apparatus supplied by Thar Process Inc., USA in the static mode. The schematics of SC-CO2 processing have been previously described in detail (Rudrangi et al., 2015) .
The physical mixtures of olanzapine and Me-β-CD (100.01 mg and 412.28 mg; 100.03 mg and 412.27 mg; 100.02 mg and 412.28 mg; 100.01 mg and 412.30 mg, respectively) were placed in a sample cell. Carbon dioxide was pumped from a cylinder via a cooling unit into the sample cell. The physical mixtures were processed at four different working conditions The desired pressure was achieved by pumping carbon dioxide against an automated backpressure regulator. The sample cell in the reaction vessel was heated to the desired temperature and held for 1 h before recovering the solid complex by depressurisation at a rate of 7-8 bar min −1 . The product was then homogenised in a mortar prior to further analysis.
Analysis of the prepared binary mixtures
Differential scanning calorimetry analysis (DSC)
Thermal analysis of pure materials and the binary mixtures was carried out using a differential scanning calorimeter (Mettler-Toledo, LLC, UK). The equipment was periodically calibrated with indium. Accurately weighed samples (5 mg) were hermetically sealed in aluminium pans and heated at a rate of 10 °C min -1 from 50°C to 200 °C.
X-ray powder diffraction analysis (XRPD)
X-ray powder diffraction analysis of pure materials and the binary mixtures was carried out at room temperature using a D8 Advance X-ray Diffractometer (Bruker, Germany) in thetatheta Bragg-Brentano geometry using reflection mode. The diffractograms were collected between 2-40° 2θ, with a step size of 0.006° and a counting time of 0.5 s per step using Cu Kα radiation. The degree of crystallinity (% Crystallinity) was determined using the amorphous subtraction method (Suryanarayanan, R. and Mitchell, A.G., 1985) .
Scanning electron microscopy analysis (SEM)
Micrographs of pure materials and the binary systems were collected using a Hitachi SU-8030 scanning electron microscope. The samples were securely mounted on aluminium stubs using double-sided adhesive tape and made electrically conductive by coating in vacuum with a thin layer of chromium (~300Å) at 30 W for 30 s. The photomicrographs were obtained at an excitation voltage of 2.0 kV and a magnification of ×350.
Solubility studies
Saturation solubility of olanzapine was measured in triplicate by adding excess amounts of the drug to 10 mL of deionised water in sealed glass containers. The solutions were agitated for 72 hours at 37 ± 0.5 °C. The solutions were then filtered (0.45 µm filter pore size) and assayed for drug concentration by ultra-violet spectroscopy (Cary 100 UV-vis, Agilent
Technologies, USA) after dilution in 10 mm quartz cuvettes.
Phase-solubility studies were carried out in triplicate as described by Higuchi and Connors (1965) . Excess amounts of olanzapine (i.e. in amounts above its solubility limit) were added to 10 mL of de-ionised water (pH 7.1) containing successively increasing concentrations (0, 5, 10, 15, 20, 25, 37 .5 and 50 × 10 -3 M) of Me-β-CD in sealed glass containers. The resultant solutions were agitated (100 rpm) at 37 ± 0.5 °C until equilibrium was attained (72 h). The suspensions were then filtered and assayed for drug concentration as described above. The apparent stability constant (K1:1) for olanzapine-Me-β-CD complexes was calculated from the slope of the linear portion of the phase solubility diagram.
Dissolution studies
Dissolution studies of olanzapine from all binary systems and olanzapine alone were performed in triplicate using USP Type II paddle method (Hanson G2 Vision® Classic 6, Chatsworth, CA). Accurately weighed samples of drug or binary mixtures, equivalent to 10 mg of olanzapine were dispersed into 900 mL of deionised water (pH 7.1) at 37 ± 0.5 °C and stirred at 50 rpm. At predetermined time points (2, 5, 10, 20, 45 , and 60 min); 5 ml aliquots of the samples were drawn, filtered (0.45 µm filter pore size) and assayed for drug concentration by UV spectroscopy. The dissolution curves were characterized by the percentage of drug dissolved and the dissolution efficiency at 30 minutes. Dissolution efficiency was evaluated according to the method reported by Khan (1975) .
Computational details
Molecular docking calculations were conducted using Glide (grid-based ligand docking) application implemented in the Maestro 9.3 software package (Schrodinger, LLC, New York, 2012). The Me-β-CD structure was prepared by adding hydrogens, followed by an energy minimisation to a convergence of RMSD 0.30Å using OPLS_2005 as force field. Olanzapine was energetically minimised and ionization considered at pH 7 using ionizer subprogram of LigPrep 2.6. The 'Generate grid' sub application of the Glide tool was utilised for the generation of grid by selecting the whole Me-β-CD structure as a receptor site to locate coordinates of the receptor centre. The generated grid was then utilised as a receptor for docking of olanzapine using the 'standard precision' (SP) flexible docking method, located in the Glide tool. Docked Me-β-CD and olanzapine complexes were visualised and molecular surface complex pictures were generated using Maestro. complete disappearance of the drug endotherm which may be ascribed to the transformation of drug from crystalline to an amorphous state, or the formation of inclusion complexes (Charoenchaitrakool et al., 2002) . The diffraction pattern of Me-β-CD showed two broad halos at 2θ equal to 11° and 18°
Results and discussions
Differential scanning calorimetry analysis
X-ray powder diffraction analysis
confirming its amorphous nature. Diffraction pattern of the binary mixture prepared by physical mixing showed a similar diffraction pattern to that of the respective drug and cyclodextrin. It displayed all the principal peaks of olanzapine, indicating the retention of the crystalline structure of drug and suggests the absence of interaction between the drug and the cyclodextrin.
In agreement with the DSC results, the diffraction patterns of the complexes prepared by SC-CO2 processing at 45 °C-200 bar and 55 °C-100 bar revealed significant diminution of the diffraction peaks suggesting the interactions between drug and Me-β-CD. The diffraction pattern of the complexes prepared by SC-CO2 processing at 55 °C-200 bar was characterised by the complete disappearance of the drug peaks. However, it displayed two broad features similar to that of the pure Me-β-CD suggesting the formation of inclusion complexes in which the drug was entrapped in the cavity of cyclodextrin (Charoenchaitrakool et al., 2002; Banchero et al,. 2013; Rudrangi et al., 2015) .
The increase in the amorphous content of the drug was observed in the following order: SC- 
Scanning electron microscopy analysis
Morphology of olanzapine, Me-β-CD and olanzapine-Me-β-CD binary systems prepared by physical mixing, freeze drying, co-evaporation and SC-CO2 processing was analyzed by SEM and is presented in Fig. 3 .
From SEM analysis, pure olanzapine ( Fig. 3a) and olanzapine processed with SC-CO2 at 55 °C-200 bar (Fig. 3b ) appeared as small to large irregularly sized and shaped crystals with a tendency to self-agglomerate while pure Me-β-CD (Fig. 3c ) appeared as perforated hollow spheres. In agreement with DSC and XRPD analyses, SEM analysis also indicated that SC-CO2 process had not altered the crystallinity of the drug.
The physical mixture (Fig. 3d) showed the presence of olanzapine crystals, mixed with, or adhered to the surface of broken hollow spheres of Me-β-CD. In agreement with the XRPD analysis, the complexes prepared by freeze drying (Fig. 3e ) and co-evaporation (Fig. 3f) showed the presence of crystalline olanzapine. Co-evaporated product appeared as aggregates of drug particles and broken spheres. The binary mixtures prepared by SC-CO2 processing at 55 °C-200 bar (Fig. 3g) revealed the disappearance of the original morphology of the drug and Me-β-CD. The product appeared as heterogeneous aggregates and it was not possible to differentiate between the raw materials.
Solubility studies
Aqueous solubility of olanzapine at 37 ± 0.5 °C was found to be 1.96 ± 0.24 µg mL -1 and 23.49 ± 1.53 µg mL -1 at the end of 1 h and 72 h, respectively. No further improvement was observed in the drug solubility after 72 h. Kulkarni et al. (2010) , Dixit et al. (2011) and Raman et al. (2013) reported a drug solubility of 13.13 ± 1.6 µg mL -1 , 34.3 ± 11.1 µg mL -1 and 43.4 ± 1.74 µg mL -1 in distilled water at 37 °C, respectively. olanzapine-Me-β-CD complexes in distilled water by de Freitas et al. (2012) .
Phase solubility studies of olanzapine-hydroxypropyl-β-cyclodextrin complexes were carried out by Kulkarni et al. (2010) in distilled water and the authors reported a stability constant of K1:1 = 242 M -1 . Phase solubility studies of indomethacin-Me-β-CD complexes were carried out by Rudrangi et al. (2015) in phosphate buffer medium (pH 7.4) and the authors reported an AN-subtype phase solubility diagram with a stability constant of K1:1 = 167 M -1 . The amount of olanzapine dissolved from unprocessed drug alone and drug processed with SC-CO2 at 55 °C-200 bar was very low with 17.62 ± 1.59% and 18.84 ± 1.44% dissolving at the end of 60 min, respectively. The dissolution studies confirmed that SC-CO2 processing alone had not affected the dissolution of the drug.
Dissolution studies
The binary mixture obtained by physical mixing exhibited no increase in the drug dissolution with 16.75 ± 1.72% of olanzapine dissolving at the end of 60 min. Similar dissolution profile was reported for olanzapine-Me-β-CD physical mixture in distilled water by de Freitas et al. (2012) .
Improvement in the drug dissolution was found to be dependent both on the processing method and the processing conditions used for the preparation of complexes. The binary mixtures prepared by freeze drying and co-evaporation exhibited an increased drug release with 34.44 ± 2.61% and 68.67 ± 3.11% of olanzapine dissolved after 60 min, respectively.
On the other hand, binary mixtures prepared by SC-CO2 processing resulted in more than 80% of drug dissolution within the first 30 min irrespective of the temperature and pressure employed. However, the binary mixtures prepared by SC-CO2 processing at 55 °C and 200 bar showed highest drug dissolution with more than 90% of the drug dissolved within the first 10 min. These results suggested that both the temperature and pressure have influence on the formation of the inclusion complexes in SC-CO2 at studied parameters.
The improved dissolution characteristics of the binary mixtures can be attributed to the improved drug wettability, high aqueous solubility (greater than 2000 mg mL -1 ) and surfactant-like properties of Me-β-CD as suggested by Banchero et al. (2013) , Cirri et al. (2005) and Guyot et al. (1995) . Moreover, the greater improvement obtained with all the SC-CO2 processed systems could also be a result of reduced crystallinity of the binary mixtures (El-Badry, M. et al., 2009 ) and the formation of inclusion complexes between olanzapine and Me-β-CD in the solid state (Rudrangi et al., 2015) .
Docking studies
Computational molecular docking studies were conducted to study the possibility of molecular arrangement of inclusion complexes between olanzapine and Me-β-CD. Fig. 6 presents the best pose of olanzapine docked in the cavity of Me-β-CD.
The three-dimensional structure of olanzapine is depicted in stick form with a mesh representing the molecular surface (grey with reddish tint in the cavity); the hydrophilic area (cyan mesh) and the hydrophobic area (orange mesh at the mid cavity depth of Me-β-CD).
The figure shows the binding of olanzapine in the cavity of Me-β-CD through anchorage by the methyl group of the piperazine due to its hydrophobicity. The interactions responsible for the inclusion seem to be purely hydrophobic in nature, as no indications of hydrogen bonding can be found in the optimal complex geometries. The binding affinity (GLIDE energy), van der Waals energy and docking score for inclusion of olanzapine in Me-β-CD are -24.13 kcal mol -1 , -21.57 kcal mol -1 and -3.09 kcal mol -1 , respectively.
Computational molecular docking studies of indomethacin with Me-β-CD were carried out by Rudrangi et al. (2015) using the Glide application and the authors reported the binding affinity, van der Waals energy and docking score of 27.880 kcal mol -1 , -28.941 kcal mol -1 and -4.882 kcal mol -1 respectively.
Conclusions
Complexation of olanzapine with Me-β-CD was accomplished successfully using a singlestep, organic solvent-free supercritical fluid process. The phase solubility diagram with Me-β-CD in de-ionised water was classified as AL-subtype, indicating the formation of 1:1 stoichiometric inclusion complexes. All the binary mixtures with Me-β-CD, except physical mixture, exhibited a faster and greater extent of drug dissolution than the drug alone.
Information obtained from the differential scanning calorimetry, X-ray powder diffraction, scanning electron microscopy and dissolution studies suggest complete complexation or amorphisation of olanzapine and Me-β-CD prepared by SC-CO2 processing method.
Different degrees of crystallinity and dissolution rate were observed in the products processed by SC-CO2 at various processing conditions, suggesting the possibility of olanzapine-Me-β-CD interactions of different efficiencies in the solid state. Products obtained by the SC-CO2 processing method exhibited the highest apparent drug dissolution followed by co-evaporation, freeze drying and physical mixing. Therefore, a solid inclusion method using SC-CO2 proved to be a novel and efficient complexation method for olanzapine into Me-β-CD. Furthermore, since this method has no toxic solvent residue, products obtained by this method should provide minimal side effects in humans, compared to those obtained by techniques, which require the use of organic solvents.
Al-Marzouqi, A.H., Jobe, B., Corti, G., Cirri, M., Mura, P., 2007b was calculated from the area under the dissolution curve at 30 min and expressed as a percentage of the area of the rectangle described by 100% dissolution in the same time of the total amount added.
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